Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Macrocytic Anemia during Low-dose Cisplatin and 5-Fluorouracil through Implanted Infusion Port for Unresectable Hepatobilliary Malignancies

NORIHIKO YAMAMOTO, KAZUMOTO MURATA, HIROYUKI FUKE, TOMOKO INOUE, YUTAKA YAMANAKA, YUKIKO SAITOU, KEIICHI ITO, KAZUSHI SUGIMOTO, MUTSUMI KOYAMA, KATSUYA SHIRAKI and TAKESHI NAKANO
Anticancer Research March 2005, 25 (2B) 1243-1246;
NORIHIKO YAMAMOTO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUMOTO MURATA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: atarum@clin.medic.mieu.ac.jp
HIROYUKI FUKE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOKO INOUE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUTAKA YAMANAKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUKIKO SAITOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KEIICHI ITO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KAZUSHI SUGIMOTO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MUTSUMI KOYAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KATSUYA SHIRAKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKESHI NAKANO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The efficacy of continuous arterial infusion chemotherapy through a subcutaneously implanted port has been reported with less adverse effects than systemic chemotherapy in hepatobilliary malignancies. However, macrocytic anemia is sometimes seen during this therapy. In 25 patients (22 with hepatocellular carcinoma, 3 with cholangiocellular carcinoma) treated with cisplatinum (10mg/day) and 5-Fluorouracil (5-FU) (250 mg/day), the frequency of anemia and its etiologies were evaluated. Moreover, the two groups (“anemia” and “no anemia” group) were compared with their backgrounds. Nine cases (36%) showed macrocytic anemia without any evident etiologies during therapy. The cumulative appearance rate of anemia was 19% at 12 weeks and 51% at 18 weeks. The Child-Pugh score or Japanese integrated staging (JIS) score were significantly higher in the “anemia” group than that in the “no anemia” group. Conclusion: Attention should be paid to slow progressive macrocytic anemia during low-dose cisplatinum and 5-FU, especially in patients with advanced liver cirrhosis.

  • Macrocytic anemia
  • arterial infusion
  • hepatobiliary malignancy
  • 5-FU

Footnotes

  • Received September 24, 2004.
  • Revision received February 7, 2005.
  • Accepted February 18, 2005.
  • Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research: 25 (2B)
Anticancer Research
Vol. 25, Issue 2B
1 Mar 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Macrocytic Anemia during Low-dose Cisplatin and 5-Fluorouracil through Implanted Infusion Port for Unresectable Hepatobilliary Malignancies
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
9 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Macrocytic Anemia during Low-dose Cisplatin and 5-Fluorouracil through Implanted Infusion Port for Unresectable Hepatobilliary Malignancies
NORIHIKO YAMAMOTO, KAZUMOTO MURATA, HIROYUKI FUKE, TOMOKO INOUE, YUTAKA YAMANAKA, YUKIKO SAITOU, KEIICHI ITO, KAZUSHI SUGIMOTO, MUTSUMI KOYAMA, KATSUYA SHIRAKI, TAKESHI NAKANO
Anticancer Research Mar 2005, 25 (2B) 1243-1246;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Macrocytic Anemia during Low-dose Cisplatin and 5-Fluorouracil through Implanted Infusion Port for Unresectable Hepatobilliary Malignancies
NORIHIKO YAMAMOTO, KAZUMOTO MURATA, HIROYUKI FUKE, TOMOKO INOUE, YUTAKA YAMANAKA, YUKIKO SAITOU, KEIICHI ITO, KAZUSHI SUGIMOTO, MUTSUMI KOYAMA, KATSUYA SHIRAKI, TAKESHI NAKANO
Anticancer Research Mar 2005, 25 (2B) 1243-1246;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients
  • Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study
  • Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2023 Anticancer Research

Powered by HighWire